+

Blaze directs its R&D efforts toward development of technologies aimed at improving characterization and utilization of blood products. Blaze’s growing domestic and international patent portfolio addresses a range of systems and methods for testing blood component properties. Products currently under development will find wide utility in both biomedical research and clinical practice.

+
+

………………………Products………………………………Patents……….